- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT01837537
Respiration Rate V2.0 in a Hospital Setting
Evaluation of Respiration Rate Parameters in a Hospital Population Using a Nellcor Bedside Respiratory Patient Monitoring System With Respiration Rate Version 2.0
Study Overview
Status
Conditions
Detailed Description
Volunteer subjects from a hospital setting (see specific inclusion/exclusion criteria) over the age of 18, male and female, who provide written informed consent prior to the procedure, and are without any contact skin allergies to adhesives found in standard pulse oximetry sensors. A cross section of demographics - cardiovascular, respiratory, and metabolic type cases should be considered for a broad distribution of medical and surgical patients.
The study consists of measuring parameters related to respiration in hospitalized volunteers by means of the Bedside Respiratory Patient Monitoring System with RR V2.0 (Nightingale). The production-equivalent Nightingale device and multiparameter reference devices will be attached to the subject via sensors, nasal cannulas and ECG leads and the information from all devices will be captured continuously for up to 40 minutes to allow for at least 30 minutes of artifact free data 30 minutes.
Study Type
Enrollment (Actual)
Contacts and Locations
Study Locations
-
-
Ohio
-
Columbus, Ohio, United States, 43210
- The Ohio State University Wexner Medical Center
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Genders Eligible for Study
Sampling Method
Study Population
Description
Inclusion Criteria:
- Male or female.
- 18 years or older.
- A patient at the study site on a General Care Floor or General Surgery Care Floor.
- Subject is willing and able to provide written consent.
Exclusion Criteria:
- Subject is younger than 18.
- Subject has severe contact allergies that may cause a reaction to standard adhesive materials found in pulse oximetry sensors, ECG electrodes, respiration monitor electrodes or other medical sensors.
- Subject has an abnormality that may prevent proper application of the device.
- Subject is in atrial fibrillation.
- Subject has a documented history of frequent premature ventricular contractions (PVCs), defined as greater than 3 in 30 seconds or greater than 6 in 60 seconds.
- Subject has an implanted pacemaker.
- Subject is unwilling or unable to sign informed consent.
Study Plan
How is the study designed?
Design Details
Cohorts and Interventions
Group / Cohort |
|---|
|
no treatment
no treatment, prospective observational
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Mean Error (ME) +/- 1 Breath Per Minute, RR Sensor
Time Frame: up to 40 minutes of continuous monitoring
|
The software calculates respiration rate values via Adult Respiratory Sensor with a mean error of +/- 1 breath per minute relative to a capnography based reference.
The Mean Error value estimates the mean difference in simultaneous estimates of respiration rate (the Respiration Rate calculated from the sensor and the Respiration Rate calculated from capnography).
|
up to 40 minutes of continuous monitoring
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Mean Error (ME) +/- 1 Breath Per Minute, Max-N Sensor
Time Frame: up to 40 minutes of continuous monitoring
|
The software calculates respiration rate values via the Max-N Sensor with a mean error of +/- 1 breath per minute relative to a capnography based reference.
The Mean Error value estimates the mean difference in simultaneous estimates of respiration rate (the Respiration Rate calculated from the sensor and the Respiration Rate calculated from capnography).
The error value estimates the mean difference in simultaneous estimates of respiration rate (the Respiration Rate calculated from the Max-N sensor minus the Respiration Rate calculated from capnography.
|
up to 40 minutes of continuous monitoring
|
Collaborators and Investigators
Sponsor
Study record dates
Study Major Dates
Study Start
Primary Completion (Actual)
Study Completion (Actual)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Estimate)
Study Record Updates
Last Update Posted (Actual)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Other Study ID Numbers
- COVMOPR0399
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Respiratory Rate
-
ContinUse Biometrics Ltd.CompletedHeart Rate | Respiratory RateIsrael
-
KK Women's and Children's HospitalRenew GroupCompletedHeart Rate | Respiratory Rate | Vital SignSingapore
-
University Hospital Southampton NHS Foundation...University of SouthamptonCompletedExercise | Heart Rate | Respiratory RateUnited Kingdom
-
KK Women's and Children's HospitalRenew GroupActive, not recruitingHeart Rate | Respiratory Rate | Vital SignSingapore
-
Life Detection TechnologiesNilo Medical Consulting GroupRecruiting
-
New York University Abu DhabiIQAir AG; LUT UniversityCompletedSleep | Heart Rate | Respiratory Rate | Air Pollution Exposure | SpO2 | HRV | Resting Heart RateUnited Arab Emirates
-
MX LABS spółka z ograniczoną odpowiedzialnością...CompletedHeart Rate Variability | Heart Rate | Respiratory RatePoland
-
Eupnea ASHaraldsplass Deaconess HospitalCompletedRespiratory Rate | Capnography | Wireless Vital Signs Monitoring System | Respiratory Rate Accuracy TestNorway
-
Heroic Faith Medical Science Co., Ltd.Elite BioMedical Consulting IncCompleted
-
Rijnstate HospitalCompleted